Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with b-thalassaemia: results from the ESCALATOR study

Citation:
Taher, A., M. S. Elalfy, K. A. Zir, S. Daar, A. A. Jefri, D. Habr, U. Kriemler-Krahn, A. El-Ali, B. Roubert, and A. El-Beshlawy, "Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with b-thalassaemia: results from the ESCALATOR study", European Journal of Haematology, vol. 87, pp. 349-354, 2011.

Abstract:

This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with ?-thalassaemia from the ESCALATOR trial (n = 231).

Notes:

n/a

PreviewAttachmentSize
CU-PDF205.08 KB
Tourism